Janssen joins U.K. schools in phenotype initiative

The University of Dundee, University of Edinburgh and University of Oxford launched the Phenomics Discovery Initiative (PDi), which intends to develop phenotypic assays for drug discovery. The Janssen Pharmaceutica N.V. unit of Johnson & Johnson (NYSE:JNJ) is the initiative's first industry partner.

Phenotypic screens help identify drug candidates by systematically measuring biological changes that compounds induce in cells, tissues or organisms. ...